Search Results 891-900 of 17556 for treatment resistant depression
... therapy of TILT-123 and pembrolizumab in patients with platinum resistant or refractory ovarian cancer. BiCaZO: A Study Combining Two Immunotherapies ...
2023 Gerstner Awardee's 'evolutionary therapy' targets pancreatic cancer treatment resistance featured image. Research. 2023 Gerstner Awardee's 'evolutionary ...
Mayo Clinic study finds majority of midlife women with menopause symptoms do not seek care featured · Mayo Clinic discovery of breast cancer treatment resistance ...
This will be done by looking at the pharmacokinetics of MT-0169after a single dose and after repeat doses in people with relapsed or refractory multiple myeloma ...
Nightmare disorder involves disturbing or scary dreams that awaken you, causing distress or preventing adequate sleep.
Natural remedies for depression: Are they effective? Nearsightedness · Neti ... Treatment-resistant depression · Trichinosis · Tricyclic antidepressants and ...
A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma · Overview · Participation eligibility · Participating Mayo Clinic locations.
The purpose of this study is to determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory ...
August 2, 2023. 2023 Gerstner Awardee's 'evolutionary therapy' targets pancreatic cancer treatment resistance featured image. Research. 2023 Gerstner Awardee's ...
Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia. Rochester, Minn. This phase I trial evaluates the safety, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!